SG001 is a Class I new drug developed independently by Sumgen, with tumors as its indications.
SG301 is a Class I new drug, an innovative monoclonal antibody developed by Sumgen, with hematological malignant tumors
SG404 is a Class I new drug, an innovative fusion protein developed by Sumgen, with advanced malignant tumors as its ind
SG2501 is a Class I new drug, a First in Class innovative bispecific antibody developed by Sumgen, with hematological ma
SG12473 is a Class I new drug, an innovative bispecific antibody developed by Sumgen, with advanced malignant tumors as
Copyright Rm. 301, F3, Building C, Block 2, No. 688, Bin'an Road, Changhe Zhejiang ICP Filing No. 18039044